… NE Cameron et al.: vascular factors in diabetic neuropathy … NE Cameron et al.: vascular
factors in diabetic neuropathy … NE Cameron et al.: vascular factors in diabetic neuropathy 1978 …

… treatment with the selective ETA receptor antagonist BQ123 following 6 weeks of untreated
diabetes on sciatic motor NCV and nutritive blood flow are shown in Figure4 (Cameron NE, …

… panied by a normalization of thermal hyperalgesia, tactile allodynia, and a partial correction
of mechanical hyperalgesia (NE Cameron and MA Cotter 2005, unpublished observations). …

… Cotter MA, Cameron NE: Reversal of neurovascular dysfunction by chronic antioxidant
and aminoguanidine treatments in anaesthetized diabetic rats: modulation by nitric oxide …

… CAMERON,NORMAN E., MARY A. COTTER,AND PHILLIP A. LOW. … NE Cameron was
supported by a Wellcome … COTTER, MA, NE CAMERON, …

Increased oxygen free radical activity, coupled with reduced protection against oxidative
stress, could play a role in the aetiology of neurovascu-lar abnormalities in experimental …

Neuropathies of the peripheral and autonomic nervous systems affect up to half of all people
with diabetes, and are major risk factors for foot ulceration and amputation. The aetiology is …

NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to
explore the current status of animal models of diabetic peripheral neuropathy. The goal of the …

Advanced glycation and lipoxidation end products (AGEs/ALEs) have been implicated in the
pathogenesis of the major microvascular complications of diabetes mellitus: nephropathy, …

Reactive oxygen species (ROS) are elevated by metabolic changes in diabetes, including
autoxidation and increased advanced glycation. Endogenous protection by the glutathione …